Normal view MARC view ISBD view

One-day diagnosis for hepatobiliary and pancreatic lesions: An innovative patient-centered care pathway organization. [electronic resource]

By:

Pessaux, P

Contributor(s):

Producer: 20191028Description: 439-443 p. digitalISSN:

1878-7886

Subject(s):

Online resources:

Available from publisher's website

In: Journal of visceral surgery vol. 155

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

No physical items for this record

Publication Type: Journal Article

There are no comments on this title.

to post a comment.

Back to results

401 [Symptomatic calcification in the newborn. Phenocopies of chondrodysplasia punctata].
by Leicher-Düber, A
402 Peroxisomal integral membrane proteins in livers of patients with Zellweger syndrome, infantile Refsum's disease and X-linked adrenoleukodystrophy.
by Small, G M
403 [Clinical and molecular aspects of peroxisome-deficient disorders].
by Suzuki, Y
404 Mutations in the peroxin Pex26p responsible for peroxisome biogenesis disorders of complementation group 8 impair its stability, peroxisomal localization, and interaction with the Pex1p x Pex6p complex.
by Furuki, Satomi
405 Analysis of a Chinese pedigree with Zellweger syndrome reveals a novel PEX1 mutation by next-generation sequencing.
by Sun, Yan
406 Acyl-CoA oxidase, peroxisomal thiolase and dihydroxyacetone phosphate acyltransferase: aberrant subcellular localization in Zellweger syndrome.
by van Roermund, C W
407 Disturbed cholesterol homeostasis in a peroxisome-deficient PEX2 knockout mouse model.
by Kovacs, Werner J
408 Defective PEX gene products correlate with the protein import, biochemical abnormalities, and phenotypic heterogeneity in peroxisome biogenesis disorders.
by Shimozawa, N
409 13-(S)-hydroxyoctadecadienoic acid (13-HODE) incorporation and conversion to novel products by endothelial cells.
by Fang, X
410 Bile acid analysis in human disorders of bile acid biosynthesis.
by Vaz, Frédéric M
411 Bile acid synthetic defects and liver disease.
by Bove, K E
412 Identification of a novel PEX14 mutation in Zellweger syndrome.
by Huybrechts, S J
413 Liver disease in infancy: a 20 year perspective.
by Mieli-Vergani, G
414 Adrenoleukodystrophy and other peroxisomal diseases.
by Aubourg, P
415 [PMP70, the 70-kDa peroxisomal membrane protein: a member of the ATP-binding cassette transporters].
by Kamijo, K
416 Pathogenesis of peroxisomal deficiency disorders (Zellweger syndrome) may be mediated by misregulation of the GABAergic system via the diazepam binding inhibitor.
by Breitling, Rainer
417 Diagnostic and prognostic value of in vivo proton MR spectroscopy for Zellweger syndrome spectrum patients.
by Rosewich, H
418 Mutations in the 70K peroxisomal membrane protein gene in Zellweger syndrome.
by Gärtner, J
419 Docosahexaenoic acid deficit is not a major pathogenic factor in peroxisome-deficient mice.
by Janssen, A
420 Induction of peroxisomal changes in oligodendrocytes treated with 7-ketocholesterol: Attenuation by α-tocopherol.
by Nury, Thomas